Retail & Brands

Boots Launches Private Medical Cannabis Service in UK High-Street First

The pharmacy chain has launched SureLeaf, an online medical cannabis service for patients aged 25 and over who have not found relief from conventional treatments.

Boots has launched a private medical cannabis service for patients with chronic pain, anxiety and insomnia, it has announced, in a first for a UK high street pharmacy.

The online service called SureLeaf is being offered to eligible patients in the UK aged 25 and older who have an eligible condition. 

It will offer consultations with specialist doctors, prescriptions and regular follow-up appointments to eligible patients who have already tried conventional treatments.

The pharmacy chain said it is launching its SureLeaf service alongside a collaborative research programme with the University of Nottingham that will look at patient outcomes, prescribing practices and experience in the treatment of chronic pain.

Jamie Kerruish, Chief Healthcare Officer at Boots, said: “Medical cannabis is a specialist area of healthcare and, through SureLeaf, we’re giving eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care.”

How will Boots’ medical cannabis service work?

Patients will begin with an online assessment to establish whether they may be suitable for treatment in flower or oil form.

Those who meet the initial criteria will be offered a video consultation with a doctor on the General Medical Council’s Specialist Register. 

Any proposed prescription will then be reviewed by a multidisciplinary clinical team, including a second independent consultant, before treatment can begin.

Patients will receive an initial follow-up after 28 days, followed by reviews at least every three months.

Boots said clinicians will use standardised questionnaires to monitor patients’ symptoms, quality of life, pain, anxiety, sleep and mood throughout treatment.

Dr David Gwynne, Medical Director of Boots Online Doctor, said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.”

Who will be eligible for medical cannabis through Boots?

SureLeaf will accept patients aged 25 and over with eligible chronic pain conditions, generalised anxiety disorder or insomnia disorder, provided they meet the service’s clinical criteria.

The chronic pain conditions covered include fibromyalgia, neuropathic pain, osteoarthritis, rheumatoid arthritis, sciatica, chronic back and neck pain, chronic migraine and endometriosis-related pelvic pain.

Other eligible conditions include complex regional pain syndrome, peripheral neuropathy, trigeminal neuralgia, phantom limb pain and chronic abdominal or pancreatic pain.

Patients must have previously tried conventional treatments without adequate symptom relief. 

TopicsAnxietyBootscannabis prescriptionsChronic PainInsomniamedical cannabisMedical Cannabis ClinicsPrivate Healthcare

Spotted an error, or have a tip? Contact the newsroom.

Up next · Retail & Brands

German Cannabis Pioneer SynBiotic SE Files For Insolvency

Ben Stevens · 28 October 2026

More